Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

被引:35
|
作者
Sorrig, Rasmus [1 ,2 ]
Klausen, Tobias W. [3 ]
Salomo, Morten [1 ]
Vangsted, Annette [1 ,2 ]
Gimsing, Peter [1 ]
机构
[1] Rigshosp, Dept Hematol, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Herlev Hosp, Hematol Res Lab, Herlev, Denmark
关键词
immunoparesis; infection; multiple myeloma; risk factors; STEM-CELL TRANSPLANTATION; T-REGULATORY CELLS; HIGH-DOSE THERAPY; IMMUNE STATUS; EARLY DEATH; MORBIDITY; MORTALITY;
D O I
10.1111/ejh.13190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Infections pose the greatest risk of early death in patients with Multiple Myeloma. However, few studies have analyzed the risk factors for infections in Multiple Myeloma patients. The aim of this study was to analyze the risk factors infections within a population-based MM cohort. Methods Using Danish registries (from 2005 to 2013), we analyzed all ICD-10 codes for infections within the first 6 months of Multiple Myeloma diagnosis in 2557 patients. Results Pneumonia and sepsis represented 46% of infections. Multivariable regression analysis showed that risk factors for pneumonia were male gender (HR 1.4; P = 0.001), ISS II (HR 1.6; P = 0.0004) and ISSIII (HR 1.8; P = 0.0004) and elevated LDH (HR 2.6; P = 0.0008). Risk factors for sepsis were high bone marrow plasma cell % (HR 1.1; P = 0.038), ISS II (HR 1.7; P = 0.007) ISS III (HR 2.0; P = 0.002) and creatinine (HR 2.1; P = 0.002). Neither immunoparesis (hypogammaglobulinemia) nor comorbidity was significant risk factors. Conclusions Our study suggests that tumor burden and renal impairment are risk factors for pneumonia and sepsis in the early phase of Multiple Myeloma.
引用
收藏
页码:182 / 190
页数:9
相关论文
共 50 条
  • [21] Risk factors of major infections in schizophrenia. A nationwide Danish register study
    Pankiewicz-Dulacz, M.
    Stenager, E.
    Chen, M.
    Stenager, E. N.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2019, 121 : 60 - 67
  • [22] Clinical characteristics and survival outcomes of newly diagnosed multiple myeloma patients presenting with extramedullary disease: A retrospective study
    Gao, Shuang
    Li, Qihui
    Dong, Fei
    Yang, Ping
    Chen, Yingtong
    Wang, Jing
    Wang, Yanfang
    Jing, Hongmei
    LEUKEMIA RESEARCH, 2022, 115
  • [23] Frontline therapy for newly diagnosed patients with multiple myeloma
    Jung, Sung-Hoon
    Jo, Jae-Cheol
    Song, Ga-Young
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Ahn, Jae-Sook
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    BLOOD RESEARCH, 2020, 55 : 37 - 42
  • [24] Treatment for patients with newly diagnosed multiple myeloma in 2015
    Mateos, Maria-Victoria
    Ocio, Enrique M.
    Paiva, Bruno
    Rosinol, Laura
    Martinez-Lopez, Joaquin
    Blade, Joan
    Lahuerta, Juan-Jose
    Garcia-Sanz, Ramon
    San Miguel, Jesus F.
    BLOOD REVIEWS, 2015, 29 (06) : 387 - 403
  • [25] Cytogenetic abnormalities in patients with newly diagnosed multiple myeloma as a secondary primary malignancy: a retrospective study
    Wang, Yiting
    Wu, Yong
    Xu, Zhenshu
    Zhou, Huarong
    Chen, Yuanzhong
    Zhan, Rong
    HEMATOLOGY, 2020, 25 (01) : 176 - 180
  • [26] Epidemiology and Risk Factors for the Development of Infectious Complications in Newly Diagnosed Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America
    Bove, Virginia
    Riva, Eloisa
    Vasquez, Jule
    Pena, Camila
    Seehaus, Cristian
    Samanez, Cesar
    Bustos, Justina
    Hernandez, Marcos
    Fernandez, Julio
    Rios, Oliday
    Rodriguez, Yusaima
    Figueredo, Irving
    Fantl, Dorotea
    Malpica, Luis
    JCO GLOBAL ONCOLOGY, 2022, 8 : e2200068
  • [27] Risk of infections and mortality in Danish patients with cancer diagnosed with bone metastases: a population-based cohort study
    Hjelholt, Thomas Johannesson
    Rasmussen, Thomas Bojer
    Seesaghur, Anouchka
    Hernandez, Rohini K.
    Marongiu, Andrea
    Obel, Niels
    Sorensen, Henrik T. Toft
    Pedersen, A. B.
    BMJ OPEN, 2021, 11 (12):
  • [28] Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma
    Bici, Anisa
    Pianko, Matthew J.
    Nachar, Victoria R.
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 407 - 414
  • [29] Substratification of patients with newly diagnosed standard-risk multiple myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 254 - 260
  • [30] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Chun-Kuang Tsai
    Chiu-Mei Yeh
    Te-Lin Hsu
    Chia-Ju Li
    Chian Tin
    Liang-Tsai Hsiao
    Yao-Chung Liu
    Hao-Yuan Wang
    Po-Shen Ko
    Po-Min Chen
    Jin-Hwang Liu
    Jyh-Pyng Gau
    Chia-Jen Liu
    Supportive Care in Cancer, 2021, 29 : 3991 - 3999